Incontinence, Urge Clinical Trial
Official title:
A Pivotal Study to Assess the Performance, Safety and Usability of a New 5 French Air-Charged Catheter for Performing Urodynamic Studies on Pediatric Subjects
Verified date | May 2020 |
Source | Laborie Medical Technologies Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A Pivotal Study to Assess the Performance, Safety and Usability of a New 5 French Air-Charged Catheter for Performing Urodynamic Studies on Pediatric Subjects
Status | Completed |
Enrollment | 28 |
Est. completion date | October 17, 2018 |
Est. primary completion date | October 17, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 12 Years |
Eligibility |
Inclusion Criteria: - Male and Female (Children and infants, 12 years of age and younger) - Subjects who are scheduled and normally indicated for urodynamics testing, for any medically necessary reason as per the physician. Exclusion Criteria: - Subjects who suffer from bladder infections (not including subjects with asymptomatic bacteruria) - Subjects with urethral strictures - Subjects who require the use of a suprapubic catheter |
Country | Name | City | State |
---|---|---|---|
United States | University of Virginia Health System - UVA - Pediatric Urology Clinic | Charlottesville | Virginia |
United States | J.W. Ruby Memorial Hospital and WVU Medicine Children's | Morgantown | Virginia |
Lead Sponsor | Collaborator |
---|---|
Laborie Medical Technologies Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Number of Patients in Which the T-DOC® 5 Fr Catheters Are Safe in Measuring Urodynamic Pressures in Pediatric Subjects (12 Years of Age and Younger). | A binary clinician response after each UDS study is used to assess if it is clinically adequate (success) or inadequate (failure) in each patients questionnaire and presented to the clinician where safety (Yes the device is safe and No the device is not safe) will be reported. A minimum of 10 male and 10 female subjects, with an overall minimum of 28, and maximum of 33 subjects. | 2 months | |
Primary | The Number of Patients in Which the T-DOC® 5 Fr Catheters Are Effective in Measuring Urodynamic Pressures in Pediatric Subjects (12 Years of Age and Younger). | A binary clinician response after each UDS study is used to assess if it is clinically adequate (success) or inadequate (failure) in each patients questionnaire and presented to the clinician where effectiveness (Yes the device is effective and No the device is not effective) will be reported. A minimum of 10 male and 10 female subjects, with an overall minimum of 28, and maximum of 33 subjects. | 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05058326 -
Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
|
||
Recruiting |
NCT04305743 -
Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
|
Phase 4 | |
Recruiting |
NCT05362292 -
TReating Incontinence for Underlying Mental and Physical Health
|
Phase 4 | |
Active, not recruiting |
NCT06247033 -
Efficacies of Different Managements in Patients With Overactive Bladder With Stroke
|
N/A | |
Withdrawn |
NCT03753750 -
Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder
|
N/A | |
Not yet recruiting |
NCT05892575 -
The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and Loneliness
|
N/A | |
Completed |
NCT03615001 -
T-DOC® NXT Clinical Investigation
|
N/A | |
Recruiting |
NCT04094753 -
Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older People
|
||
Completed |
NCT03817931 -
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
|
Phase 4 | |
Not yet recruiting |
NCT05948397 -
To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence
|